Pharma manufacturer Kincell Bio secures US$36m in funding

Clinical development of cell therapies
Kincell Bio to develop cell therapy with US$36m funding, in a round led by Kineticos Ventures, to bring life-saving treatments to patients

Pharmaceutical manufacturer Kincell Bio has received US$36m in stealth funding, which was led by Kineticos Ventures.

 

Pharmaceutical manufacturing development 

Kincell Bio engineers cells into therapies and manufactures commercially viable immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programmes. Kincell provides analytical development, CMC consulting and early-stage GMP manufacturing focusing on immune cell therapies.

Kineticos Ventures has investments including biotechs and life science services who want to transform drug development. The company funds research into oncology, neurosciences and rare diseases. 

Kincell now has a facility at its Gainesville site, with an ambition to grow bigger. 

 

The clinical development of cell therapies

Shailesh Maingi, founder of Kineticos Ventures, will be the Chair of the Kincell Board of Directors.

“Kincell represents a significant step forward in bridging the gap between laboratory research and clinical development of cell therapies. By addressing the manufacturing challenges faced by early-stage innovators, Kincell is playing a vital role in accelerating the progress of cell therapy innovation. We are excited to support their mission to make cell therapy manufacturing more accessible and streamlined, ultimately bringing life-changing treatments to patients in need.”

Bruce Thompson, the CEO of Kincell, will also serve on the Board of Directors.

“Kincell is at the forefront of innovative cell therapy manufacturing, and I am honoured to lead this exceptional team. Our mission is to enable early-stage biotech companies to bring their life-changing therapies to patients by providing accessible and high-quality manufacturing services,” said Thompson. “With our technology-forward approach and focus on immune cell therapies, we are poised to accelerate the advancement of cell therapies from bench to bedside. I am excited about the potential impact we can make in the field and look forward to collaborating with our partners to drive innovation and improve patients' lives.”

Although Kincell didn’t quite make the list, you can read our Top 10 Pharmaceutical Manufacturers here - including Pfizer, Novartis, Sanofi, GSK, Merck, Roche, AbbVie, Bristol Myers Squibb and Central Pharma.

 

*********************************************

For more insights into Healthcare - check out the latest edition of Healthcare Digital and be sure to follow us on LinkedIn & Twitter.

Other magazines that may be of interest - Manufacturing Magazine.

*********************************************

BizClik is a global provider of B2B digital media platforms that cover 'Executive Communities' for CEO's, CFO's, CMO's, Sustainability Leaders, Procurement & Supply Chain Leaders, Technology & AI Leaders, Cyber Leaders, FinTech & InsurTech Leaders as well as covering industries such as Manufacturing, Mining, Energy, EV, Construction, Healthcare + Food & Drink.

BizClik, based in London, Dubai & New York offers services such as Content Creation, Advertising & Sponsorship Solutions, Webinars & Events.

Share

Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability

Sustainability